{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:56:35Z","timestamp":1790524595094,"version":"4.1.0"},"reference-count":276,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ejphar.2019.172657","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T11:12:25Z","timestamp":1567768345000},"page":"172657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Liver and insulin resistance: New wine in old bottle!!!"],"prefix":"10.1016","volume":"862","author":[{"given":"Bhoomika M.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh K.","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2019.172657_bib1","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/oby.20625","article-title":"Hepatic insulin clearance is the primary determinant of insulin sensitivity in the normal dog","volume":"22","author":"Ader","year":"2014","journal-title":"Obesity"},{"key":"10.1016\/j.ejphar.2019.172657_bib2","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1074\/jbc.M101521200","article-title":"Phosphorylation of Ser 307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action","volume":"277","author":"Aguirre","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172657_bib3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nm.3159","article-title":"PPAR\u03b3 signaling and metabolism: the good, the bad and the future","volume":"19","author":"Ahmadian","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2019.172657_bib4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling","volume":"4","author":"Akira","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"16","key":"10.1016\/j.ejphar.2019.172657_bib5","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2019.172657_bib6","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1172\/JCI118705","article-title":"A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies","volume":"97","author":"Almind","year":"1996","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2019.172657_bib7","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.2337\/db09-1266","article-title":"TBC1D1 regulates insulin- and contraction-induced glucose transport in mouse skeletal muscle","volume":"59","author":"An","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2019.172657_bib8","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s00125-011-2116-6","article-title":"Increased levels of the Akt-specific phosphatase PHdomain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance","volume":"54","author":"Andreozzi","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2019.172657_bib9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1172\/JCI107907","article-title":"Defect in insulin binding to receptors in obese man. Amelioration with calorie restriction","volume":"55","author":"Archer","year":"1975","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2019.172657_bib10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nm1185","article-title":"IKK-beta links inflammation to obesity-induced insulin resistance","volume":"11","author":"Arkan","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2019.172657_bib11","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2019.172657_bib12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/apt.12149","article-title":"Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program","volume":"37","author":"Armstrong","year":"2013","journal-title":"Aliment 811 Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.ejphar.2019.172657_bib13","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.2337\/db14-0804","article-title":"Dipeptidyl peptidase-4 inhibition ameliorates Western diet-induced hepatic steatosis and insulin resistance through hepatic lipid remodeling and modulation of hepatic mitochondrial function","volume":"64","author":"Aroor","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2019.172657_bib14","doi-asserted-by":"crossref","first-page":"25019","DOI":"10.1016\/S0021-9258(19)74566-9","article-title":"Role of glucokinase and glucose-6-phosphatase in the acute and chronic regulation of hepatic glucose fluxes by insulin","volume":"268","author":"Barzilai","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.ejphar.2019.172657_bib15","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.molmet.2017.07.016","article-title":"Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease","volume":"6","author":"Baumeier","year":"2017","journal-title":"Mol. Metab."},{"key":"10.1016\/j.ejphar.2019.172657_bib16","first-page":"9","article-title":"PDK1: the major transducer of PI 3-kinase actions","volume":"346","author":"Bayascas","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"16","key":"10.1016\/j.ejphar.2019.172657_bib17","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.4161\/15384101.2014.947750","article-title":"Insulin resistance in the liver: deficiency or excess of insulin?","volume":"13","author":"Bazotte","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejphar.2019.172657_bib18","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1074\/jbc.M114.603977","article-title":"Acetylation of TUG protein promotes the accumulation of GLUT4 glucose transporters in an insulin-responsive intracellular compartment","volume":"290","author":"Belman","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172657_bib19","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1172\/JCI41636","article-title":"The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans","volume":"122","author":"Benhamed","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2019.172657_bib20","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1210\/me.2002-0217","article-title":"Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator","volume":"17","author":"Berger","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ejphar.2019.172657_bib21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cmet.2007.11.013","article-title":"Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis","volume":"7","author":"Biddinger","year":"2008","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejphar.2019.172657_bib22","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/hep.26672","article-title":"Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes","volume":"59","author":"Birkenfeld","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2019.172657_bib23","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.2337\/diab.40.12.1691","article-title":"Skeletal muscle insulin receptor kinase. Effects of substrate inhibition and diabetes","volume":"40","author":"Block","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2019.172657_bib24","doi-asserted-by":"crossref","first-page":"600","DOI":"10.2337\/db09-0897","article-title":"Plasma membrane subdomain compartmentalization contributes to distinct mechanisms of ceramide action on insulin signaling","volume":"59","author":"Blouin","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2019.172657_bib25","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.1152\/ajpendo.00429.2001","article-title":"FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis","volume":"283","author":"Boden","year":"2002","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ejphar.2019.172657_bib26","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009191","article-title":"Insulin receptor signaling in normal and insulin-resistant states","volume":"6","author":"Boucher","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ejphar.2019.172657_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1478-7954-8-29","article-title":"Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence","volume":"8","author":"Boyle","year":"2010","journal-title":"Popul. Health Metrics"},{"key":"10.1016\/j.ejphar.2019.172657_bib29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.molcel.2008.02.024","article-title":"PKBa\/Akt1 acts downstream of DNA-PK in the DNA double strand break response and promotes survival","volume":"30","author":"Bozulic","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2019.172657_bib30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.tem.2008.04.001","article-title":"PHLiPPing the switch on Akt and protein kinase C signaling","volume":"19","author":"Brognard","year":"2008","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2019.172657_bib31","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1194\/jlr.M010256","article-title":"CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance","volume":"51","author":"Brown","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2019.172657_bib33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cmet.2007.12.009","article-title":"Selective versus total insulin resistance: a pathogenic paradox","volume":"7","author":"Brown","year":"2008","journal-title":"Cell Metabol."},{"issue":"5","key":"10.1016\/j.ejphar.2019.172657_bib34","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1097-2765(00)80155-0","article-title":"A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance","volume":"2","author":"Br\u00fcning","year":"1998","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2019.172657_bib35","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1600-0854.2011.01163.x","article-title":"SNA RE proteins underpin insulin-regulated GLUT4 traffic","volume":"12","author":"Bryant","year":"2011","journal-title":"Traffic"},{"key":"10.1016\/j.ejphar.2019.172657_bib36","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/BF00291077","article-title":"Rat hepatic microsomal glucose-6-phosphatase protein levels are increased in streptozotocin-induced diabetes","volume":"28","author":"Burchell","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2019.172657_bib37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm1166","article-title":"Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NFkappaB","volume":"11","author":"Cai","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2019.172657_bib38","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1096\/fj.03-0824fje","article-title":"Increased adipose tissue expression of Grb14 in several models of insulin resistance","volume":"18","author":"Cariou","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2019.172657_bib39","doi-asserted-by":"crossref","first-page":"11039","DOI":"10.1074\/jbc.M510258200","article-title":"The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice","volume":"281","author":"Cariou","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172657_bib40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-nutr-071714-034355","article-title":"The roles of mTOR complexes in lipid metabolism","volume":"35","author":"Caron","year":"2015","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.ejphar.2019.172657_bib41","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1038\/onc.2008.247","article-title":"The PTEN-PI3K pathway: of feedbacks and cross-talks","volume":"27","author":"Carracedo","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2019.172657_bib42","doi-asserted-by":"crossref","first-page":"38870","DOI":"10.1074\/jbc.M106219200","article-title":"Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members","volume":"276","author":"Cases","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172657_bib43","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.cell.2010.11.032","article-title":"Inositol pyrophosphates inhibit Akt signaling, thereby regulating insulin sensitivity and weight gain","volume":"143","author":"Chakraborty","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2019.172657_bib44","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.2337\/db12-1397","article-title":"Activation of PPARalpha ameliorates hepatic insulin resistance and steatosis in high fructose fed mice despite increased endoplasmic reticulum stress","volume":"62","author":"Chan","year":"2013","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.ejphar.2019.172657_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005561","article-title":"PPP2R5C couples hepatic glucose and lipid homeostasis","volume":"11","author":"Cheng","year":"2015","journal-title":"PLoS Genet."},{"issue":"5","key":"10.1016\/j.ejphar.2019.172657_bib46","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cmet.2006.03.006","article-title":"Identification of the tyrosine phosphatase PTP-MEG2 as an antagonist of hepatic insulin signaling","volume":"3","author":"Cho","year":"2006","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejphar.2019.172657_bib47","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1126\/science.292.5522.1728","article-title":"Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB b)","volume":"292","author":"Cho","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2019.172657_bib48","doi-asserted-by":"crossref","first-page":"22678","DOI":"10.1074\/jbc.M704213200","article-title":"Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance","volume":"282","author":"Choi","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172657_bib49","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature10383","article-title":"Antidiabetic actions of a non-agonist PPAR\u03b3 ligand blocking Cdk5-mediated phosphorylation","volume":"477","author":"Choi","year":"2011","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.ejphar.2019.172657_bib50","doi-asserted-by":"crossref","first-page":"599","DOI":"10.5483\/BMBRep.2014.47.11.174","article-title":"Revisiting PPAR\u03b3 as a target for the treatment of metabolic disorders","volume":"47","author":"Choi","year":"2014","journal-title":"BMB Rep."},{"key":"10.1016\/j.ejphar.2019.172657_bib51","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0074-7696(08)61772-6","article-title":"Membrane receptors for endocytosis in the renal proximal tubule","volume":"180","author":"Christensen","year":"1998","journal-title":"Int. Rev. Cytol."},{"key":"10.1016\/j.ejphar.2019.172657_bib52","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1194\/jlr.M001602","article-title":"FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa\/fa) obese rats","volume":"51","author":"Cipriani","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2019.172657_bib53","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/35051094","article-title":"The lipid phosphatase SHIP2 controls insulin sensitivity","volume":"409","author":"Clement","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2019.172657_bib54","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.2337\/diacare.28.5.1240","article-title":"The use of U-500 in patients with extreme insulin resistance","volume":"28","author":"Cochran","year":"2005","journal-title":"Diabetes Care"},{"issue":"22","key":"10.1016\/j.ejphar.2019.172657_bib55","doi-asserted-by":"crossref","first-page":"13972","DOI":"10.1074\/jbc.M115.638197","article-title":"Pathogenesis of selective insulin resistance in isolated hepatocytes","volume":"290","author":"Cook","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172657_bib56","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/sj.emboj.7600082","article-title":"Improved glucose homeostasis and enhanced insulin signaling in Grb14-deficient mice","volume":"23","author":"Cooney","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.ejphar.2019.172657_bib57","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00125-007-0913-8","article-title":"Isoform-specific defects of insulin stimulation of Akt\/protein kinase B (PKB) in skeletal muscle cells from type 2 diabetic patients","volume":"51","author":"Cozzone","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2019.172657_bib58","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1172\/JCI7535","article-title":"Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle","volume":"105","author":"Cusi","year":"2000","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2019.172657_bib59","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/dme.13697","article-title":"Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme","volume":"35","author":"Cusi","year":"2018","journal-title":"Diabet. Med."},{"key":"10.1016\/j.ejphar.2019.172657_bib60","doi-asserted-by":"crossref","first-page":"12939","DOI":"10.1021\/bi971157f","article-title":"Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612","volume":"36","author":"De Fea","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2019.172657_bib61","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1368-504X.2004.00389.x","article-title":"Dysfunctional fat cells, lipotoxicity and type 2 diabetes","volume":"143","author":"De Fronzo","year":"2004","journal-title":"Int. J. Clin. Pract. Suppl."},{"issue":"Suppl. 2","key":"10.1016\/j.ejphar.2019.172657_bib62","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.2337\/dc09-S302","article-title":"Skeletal muscle insulin resistance is the primary defect in type 2 diabetes","volume":"32","author":"DeFronzo","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2019.172657_bib63","first-page":"177","article-title":"Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes","volume":"5","author":"DeFronzo","year":"1997","journal-title":"Diabetes Rev."},{"key":"10.1016\/j.ejphar.2019.172657_bib64","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.coph.2011.09.015","article-title":"From PDE3B to the regulation of energy homeostasis","volume":"11","author":"Degerman","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172657_bib65","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2337\/db08-0913","article-title":"Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress","volume":"58","author":"Delibegovic","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2019.172657_bib66","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.2337\/db10-0401","article-title":"Brain insulin action regulates hypothalamic glucose sensing and the counterregulatory response to hypoglycemia","volume":"59","author":"Diggs-Andrews","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2019.172657_bib67","first-page":"E459","article-title":"Decreased expression of glucose transporter in muscle from insulin-resistant patients","volume":"260","author":"Dohm","year":"1991","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2019.172657_bib68","doi-asserted-by":"crossref","first-page":"E615","DOI":"10.1152\/ajpendo.00578.2007","article-title":"Oxidative stress-induced insulin resistance in rat skeletal muscle: role of glycogen synthase kinase-3","volume":"294","author":"Dokken","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2019.172657_bib69","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1126\/science.1079817","article-title":"TRB3: a tribbles homolog that inhibits Akt\/PKB activation by insulin in liver","volume":"300","author":"Du","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2019.172657_bib70","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1210\/edrv-9-3-319","article-title":"Insulin degradation: mechanisms, products, and significance","volume":"9","author":"Duckworth","year":"1988","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ejphar.2019.172657_bib71","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cell.2011.11.062","article-title":"Fibroblast growth factor-21 regulates PPAR\u03b3 activity and the antidiabetic actions of thiazolidinediones","volume":"148","author":"Dutchak","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2019.172657_bib72","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/dom.12680","article-title":"Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy","volume":"18","author":"Dutour","year":"2016","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ejphar.2019.172657_bib73","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a metabolic gene regulatory network downstream of mTOR complex 1","volume":"39","author":"Duvel","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2019.172657_bib74","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1126\/science.283.5407.1544","article-title":"Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene","volume":"283","author":"Elchebly","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2019.172657_bib75","doi-asserted-by":"crossref","first-page":"47944","DOI":"10.1074\/jbc.M104602200","article-title":"SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-a in the adipose tissue of obese mice","volume":"276","author":"Emanuelli","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172657_bib76","doi-asserted-by":"crossref","first-page":"15985","DOI":"10.1074\/jbc.275.21.15985","article-title":"SOCS-3 is an insulin-induced negative regulator of insulin signaling","volume":"275","author":"Emanuelli","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.ejphar.2019.172657_bib77","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s00125-018-4675-2","article-title":"Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study","volume":"61","author":"Eriksson","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2019.172657_bib78","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1089\/ars.2005.7.1040","article-title":"The molecular basis for oxidative stress-induced insulin resistance","volume":"7","author":"Evans","year":"2005","journal-title":"Antioxidants Redox Signal."},{"issue":"36","key":"10.1016\/j.ejphar.2019.172657_bib79","doi-asserted-by":"crossref","first-page":"15430","DOI":"10.1073\/pnas.0904944106","article-title":"Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity","volume":"106","author":"Fabbrini","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2019.172657_bib80","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.1074\/jbc.M109.076976","article-title":"Lysine 63-linked polyubiquitination of TAK1 at lysine 158 is required for tumor necrosis factor a- and interleukin-1b-induced IKK\/NF-kB and JNK\/AP-1 activation","volume":"285","author":"Fan","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172657_bib81","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1172\/JCI31408","article-title":"Muscle-specific knockout of PKC-lambda impairs glucose transport and induces metabolic and diabetic syndromes","volume":"117","author":"Farese","year":"2007","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2019.172657_bib82","doi-asserted-by":"crossref","first-page":"E385","DOI":"10.1152\/ajpendo.00608.2009","article-title":"Metabolic functions of atypical protein kinase C: \u201cGood\u201d and \u201cbad\u201d as defined by nutritional status","volume":"298","author":"Farese","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2019.172657_bib83","doi-asserted-by":"crossref","first-page":"104132","DOI":"10.1155\/2015\/104132","article-title":"Does diacylglycerol accumulation in fatty liver disease cause hepatic insulin resistance?","volume":"2015","author":"Finck","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejphar.2019.172657_bib84","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.2337\/diab.41.11.1400","article-title":"Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects","volume":"41","author":"Fulcher","year":"1992","journal-title":"Diabetes"},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2019.172657_bib85","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/dom.13001","article-title":"Recent new insights into the role of SNA RE and associated proteins in insulin granule exocytosis","volume":"19","author":"Gaisano","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ejphar.2019.172657_bib86","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1172\/JCI88491","article-title":"Ca2+ channel clustering with insulin-containing granules is disturbed in type 2 diabetes","volume":"127","author":"Gandasi","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2019.172657_bib87","doi-asserted-by":"crossref","first-page":"48115","DOI":"10.1074\/jbc.M209459200","article-title":"Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex","volume":"277","author":"Gao","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172657_bib88","doi-asserted-by":"crossref","first-page":"24944","DOI":"10.1074\/jbc.M300423200","article-title":"Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases","volume":"278","author":"Gao","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172657_bib89","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1172\/JCI1557","article-title":"Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance","volume":"101","author":"Garvey","year":"1998","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2019.172657_bib90","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1023\/A:1006812218502","article-title":"Regulation of the insulin signalling pathway by cellular protein-tyrosine phosphatases","volume":"182","author":"Goldstein","year":"1998","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2019.172657_bib91","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.2337\/diab.37.10.1316","article-title":"Rapid reduction and return of surface insulin receptors after exposure to brief pulses of insulin in perifused rat hepatocytes","volume":"37","author":"Goodner","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2019.172657_bib92","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1210\/me.2008-0473","article-title":"MBX-102\/JNJ39659100, a novel peroxisome proliferator-activated receptor-ligand with weak transactivation activity retains antidiabetic properties in the absence of weight gain and edema","volume":"23","author":"Gregoire","year":"2009","journal-title":"Mol. Endocrinol."},{"issue":"11","key":"10.1016\/j.ejphar.2019.172657_bib93","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.bbadis.2014.08.004","article-title":"Nonalcoholic fatty liver disease: a main driver of insulin resistance or a dangerous liaison?","volume":"1842","author":"Gruben","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2019.172657_bib94","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nm780","article-title":"A futile metabolic cycle activated in adipocytes by antidiabetic agents","volume":"8","author":"Guan","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2019.172657_bib277","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1128\/MCB.00138-09","article-title":"The Irs1 branch of the insulin signaling cascade plays a dominant role in hepatic nutrient homeostasis","volume":"29","author":"Guo","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejphar.2019.172657_bib95","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1038\/ncomms6190","article-title":"Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors","volume":"5","author":"Haeusler","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2019.172657_bib96","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1042\/CS20120378","article-title":"Insulin signalling to the kidney in health and disease","volume":"124","author":"Hale","year":"2013","journal-title":"Clin. Sci. (Lond.)"},{"issue":"7564","key":"10.1016\/j.ejphar.2019.172657_bib97","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nature14557","article-title":"The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1","volume":"524","author":"Han","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2019.172657_bib98","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/BF00404079","article-title":"Decreased tyrosine kinase activity in partially purified insulin receptors from muscle of young, non-obese first degree relatives of patients with type 2 (non-insulin-dependent) diabetes mellitus","volume":"36","author":"Handberg","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2019.172657_bib99","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1074\/mcp.M800407-MCP200","article-title":"The phosphotyrosine interactome of the insulin receptor family and its substrates IRS-1 and IRS-2","volume":"8","author":"Hanke","year":"2009","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.ejphar.2019.172657_bib100","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.biochem.66.1.581","article-title":"Regulation of phosphoenolpyruvatecarboxykinase (GTP) gene expression","volume":"66","author":"Hanson","year":"1997","journal-title":"Annu. Rev. Biochem."},{"issue":"39","key":"10.1016\/j.ejphar.2019.172657_bib101","doi-asserted-by":"crossref","first-page":"15466","DOI":"10.1073\/pnas.0705407104","article-title":"PAS kinase is required for normal cellular energy balance","volume":"104","author":"Hao","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"13","key":"10.1016\/j.ejphar.2019.172657_bib102","doi-asserted-by":"crossref","first-page":"E1796","DOI":"10.1073\/pnas.1520686113","article-title":"Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats","volume":"113","author":"Harriman","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2019.172657_bib103","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/0026-0495(95)90048-9","article-title":"Amplification and analysis of promoter region of insulin receptor gene in a patient with leprechaunism associated with severe insulin resistance","volume":"44","author":"Haruta","year":"1995","journal-title":"Metabolism"},{"issue":"39","key":"10.1016\/j.ejphar.2019.172657_bib104","doi-asserted-by":"crossref","first-page":"37099","DOI":"10.1074\/jbc.M304481200","article-title":"Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals","volume":"278","author":"Harwood","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ejphar.2019.172657_bib105","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2009.03.016","article-title":"Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein","volume":"137","author":"He","year":"2009","journal-title":"Cell"},{"issue":"6551","key":"10.1016\/j.ejphar.2019.172657_bib106","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0140-6736(49)90797-7","article-title":"The syndrome of diabetes mellitus and its causes","volume":"253","author":"Himsworth","year":"1949","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2019.172657_bib107","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature01137","article-title":"A central role for JNK in obesity and insulin resistance","volume":"420","author":"Hirosumi","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2019.172657_bib108","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1210\/me.2008-0386","article-title":"Dual ablation of Grb10 and Grb14 in mice reveals their combined role in regulation of insulin signaling and glucose homeostasis","volume":"23","author":"Holt","year":"2009","journal-title":"Mol. Endocrinol."},{"issue":"1","key":"10.1016\/j.ejphar.2019.172657_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146337","article-title":"The selective SGLT2 inhibitor ipragliflozin has a therapeutic effect on nonalcoholic steatohepatitis in mice","volume":"11","author":"Honda","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2019.172657_bib110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012537","article-title":"Myeloid differentiation factor 88 (MyD88)-deficiency increases risk of diabetes in mice","volume":"5","author":"Hosoi","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2019.172657_bib111","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1111\/j.1582-4934.2008.00246.x","article-title":"Transgenic mice overexpressing human G972R IRS-1 showimpaired insulin action and insulin secretion","volume":"12","author":"Hribal","year":"2008","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2019.172657_bib112","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1091\/mbc.e12-10-0765","article-title":"Insulin responsiveness of glucose transporter 4 in 3T3-L1 cells depends on the presence of sortilin","volume":"24","author":"Huang","year":"2013","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ejphar.2019.172657_bib113","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/bbrc.1994.1206","article-title":"Macrophage differentiation marker MyD88 is a member of the Toll\/IL-1 receptor family","volume":"199","author":"Hultmark","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.ejphar.2019.172657_bib114","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bcp.2015.08.098","article-title":"A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression","volume":"98","author":"Hwang","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172657_bib115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1210\/en.2006-0692","article-title":"Interleukin-1b-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression","volume":"148","author":"Jager","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2019.172657_bib116","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.tem.2017.05.002","article-title":"Update on GLUT4 vesicle traffic: a cornerstone of insulin action","volume":"28","author":"Jaldin-Fincati","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ejphar.2019.172657_bib117","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.dsx.2014.09.015","article-title":"PPAR gamma gene--a review","volume":"9","author":"Janani","year":"2015","journal-title":"Diabetes Metab. Syndr."},{"key":"10.1016\/j.ejphar.2019.172657_bib118","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1038\/ncomms4878","article-title":"Hepatocyte Toll-like receptor 4 regulates obesity-induced inflammation and insulin resistance","volume":"5","author":"Jia","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2019.172657_bib119","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.cmet.2012.03.005","article-title":"Diacylglycerol activation of protein kinase Cepsilon and hepatic insulin resistance","volume":"15","author":"Jornayvaz","year":"2012","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejphar.2019.172657_bib120","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00125-017-4511-0","article-title":"Adapting to insulin resistance in obesity: role of insulin secretion and clearance","volume":"61","author":"Jung","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2019.172657_bib121","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1210\/en.2007-0820","article-title":"Impact of transgenic overexpression of SH2-containing inositol 50- phosphatase 2 on glucose metabolism and insulin signaling in mice","volume":"149","author":"Kagawa","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2019.172657_bib122","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.2337\/diab.45.11.1644","article-title":"Glucose transport: pivotal step in insulin action","volume":"45","author":"Kahn","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2019.172657_bib123","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJM197604012941401","article-title":"The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man","volume":"294","author":"Kahn","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2019.172657_bib124","doi-asserted-by":"crossref","first-page":"26602","DOI":"10.1074\/jbc.M601284200","article-title":"Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance","volume":"281","author":"Kamei","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ejphar.2019.172657_bib125","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.metabol.2015.10.010","article-title":"The SGLT2 inhibitor empagliflozin improves insulin sensitivity in db\/db mice both as monotherapy and in combination with linagliptin","volume":"65","author":"Kern","year":"2016","journal-title":"Metabolism"},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2019.172657_bib126","article-title":"PASsing on signals: PAS kinase (PASK)-mTOR signaling conveys nutrient sufficiency signals to epigenetic (COMPASS) complexes to activate stem cell differentiation program (P15-009-19)","volume":"3","author":"Kikani","year":"2019","journal-title":"Curr. Dev. Nutr."},{"key":"10.1016\/j.ejphar.2019.172657_bib127","doi-asserted-by":"crossref","first-page":"8456","DOI":"10.1074\/jbc.275.12.8456","article-title":"Mechanism of insulin resistance in A-ZIP\/F-1 fatless mice","volume":"275","author":"Kim","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ejphar.2019.172657_bib128","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s12272-016-0864-z","article-title":"Prevention and treatment effect of evogliptin on hepatic steatosis in high-fat-fed animal models","volume":"40","author":"Kim","year":"2017","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejphar.2019.172657_bib129","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.1128\/MCB.19.9.6286","article-title":"Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serinethreonine kinase Akt","volume":"19","author":"Kitamura","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejphar.2019.172657_bib130","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1128\/MCB.20.15.5479-5489.2000","article-title":"Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in proteintyrosine phosphatase 1B-deficient mice","volume":"20","author":"Klaman","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejphar.2019.172657_bib131","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.2337\/db14-0568","article-title":"Insulin action in brain regulates systemic metabolism and brain function","volume":"63","author":"Kleinridders","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2019.172657_bib132","doi-asserted-by":"crossref","first-page":"C879","DOI":"10.1152\/ajpcell.00069.2014","article-title":"Signal transduction meets vesicle traffic: the software and hardware of GLUT4 translocation","volume":"306","author":"Klip","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ejphar.2019.172657_bib133","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.biocel.2003.10.002","article-title":"Hepatocytes: critical for glucose homeostasis","volume":"36","author":"Klover","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.ejphar.2019.172657_bib134","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0168-8227(89)90098-3","article-title":"Insulin resistance and diabetes, mechanism and possible intervention","volume":"7","author":"Koffler","year":"1989","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.ejphar.2019.172657_bib135","doi-asserted-by":"crossref","first-page":"F1227","DOI":"10.1152\/ajprenal.90351.2008","article-title":"Insulin uptake across the luminal membrane of the rat proximal tubule in vivo and in vitro","volume":"296","author":"Kolman","year":"2009","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"3","key":"10.1016\/j.ejphar.2019.172657_bib136","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151511","article-title":"Ipragliflozin improves hepatic steatosis in obese mice and liver dysfunction in type 2 diabetic patients irrespective of body weight reduction","volume":"11","author":"Komiya","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2019.172657_bib137","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cmet.2012.07.004","article-title":"Selective insulin and leptin resistance in metabolic disorders","volume":"16","author":"Konner","year":"2012","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejphar.2019.172657_bib138","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nm1044","article-title":"PGC-1 promotes insulin resistance in liver through PPAR-a-dependent induction of TRB-3","volume":"10","author":"Koo","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2019.172657_bib139","doi-asserted-by":"crossref","first-page":"E859","DOI":"10.1152\/ajpendo.00165.2014","article-title":"The regulation of glucose metabolism: implications and considerations for the assessment of glucose homeostasis in rodents","volume":"307","author":"Kowalski","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2019.172657_bib140","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.bcp.2012.05.003","article-title":"Hyperactivation of protein phosphatase 2A in models of glucolipotoxicity and diabetes: potential mechanisms and functional consequences","volume":"84","author":"Kowluru","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172657_bib141","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2337\/diab.40.11.1397","article-title":"Development of muscle insulin resistance after liver insulin resistance in high fat- fed rats","volume":"40","author":"Kraegen","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2019.172657_bib278","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cmet.2008.05.007","article-title":"Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding","volume":"8","author":"Kubota","year":"2008","journal-title":"Cell Metabol"},{"key":"10.1016\/j.ejphar.2019.172657_bib142","doi-asserted-by":"crossref","first-page":"16381","DOI":"10.1073\/pnas.1113359108","article-title":"Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease","volume":"108","author":"Kumashiro","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2019.172657_bib143","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00125-010-1931-5","article-title":"Toll-like receptor 2 deficiency improves insulin sensitivity and hepatic insulin signalling in the mouse","volume":"54","author":"Kuo","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2019.172657_bib144","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1128\/MCB.25.6.2498-2510.2005","article-title":"Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue","volume":"25","author":"Kurlawalla-Martinez","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejphar.2019.172657_bib145","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.beem.2016.06.006","article-title":"Non-alcoholic fatty liver disease and risk of type 2 diabetes","volume":"30","author":"Lallukka","year":"2016","journal-title":"Best Pract. Res. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.ejphar.2019.172657_bib146","doi-asserted-by":"crossref","first-page":"E682","DOI":"10.1152\/ajpendo.00038.2002","article-title":"Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta","volume":"283","author":"Lam","year":"2002","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2019.172657_bib147","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1126\/science.1215135","article-title":"Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity","volume":"335","author":"Lamming","year":"2012","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ejphar.2019.172657_bib148","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2337\/dc18-1569","article-title":"The SGLT2 inhibitor dapagliflozin reduces liver fat but does not affect tissue insulin sensitivity: a randomized, double-blind, placebo-controlled study with 8-week treatment in type 2 diabetes patients","volume":"42","author":"Latva-Rasku","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2019.172657_bib149","first-page":"223","article-title":"New paradigm for the mechanism and treatment of insulin resistance proc. West","volume":"45","author":"Lautte","year":"2002","journal-title":"Pharmacol. Soc."},{"key":"10.1016\/j.ejphar.2019.172657_bib150","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3109\/10409238.2011.562481","article-title":"Insulin signaling to hepatic lipid metabolism in health and disease","volume":"46","author":"Leavens","year":"2011","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.ejphar.2019.172657_bib151","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1096\/fj.201700845R","article-title":"CREB\/CRTC2 controls GLP-1-dependent regulation of glucose homeostasis","volume":"32","author":"Lee","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2019.172657_bib152","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.molmet.2016.06.011","article-title":"Insulin in the nervous system and the mind: functions in metabolism, memory, and mood","volume":"5","author":"Lee","year":"2016","journal-title":"Mol. Metab."},{"key":"10.1016\/j.ejphar.2019.172657_bib153","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.cell.2011.09.050","article-title":"Adipocyte NCoR knockout decreases PPAR\u03b3 phosphorylation and enhances PPAR\u03b3 activity and insulin sensitivity","volume":"147","author":"Li","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2019.172657_bib154","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1073\/pnas.0914798107","article-title":"Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis","volume":"107","author":"Li","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejphar.2019.172657_bib155","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/nature05861","article-title":"Akt\/PKB regulates hepatic metabolism by directly inhibiting PGC-1a cription coactivator","volume":"447","author":"Li","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2019.172657_bib156","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/labinvest.2014.11","article-title":"Metabolically induced liver inflammation leads to NASH and differs from LPS- or IL-1beta-induced chronic inflammation","volume":"94","author":"Liang","year":"2014","journal-title":"Lab. Investig."},{"key":"10.1016\/j.ejphar.2019.172657_bib157","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/oby.2008.486","article-title":"Fat in liver\/muscle correlates more strongly with insulin sensitivity in rats than abdominal fat","volume":"17","author":"Lim","year":"2009","journal-title":"Obesity"},{"key":"10.1016\/j.ejphar.2019.172657_bib158","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cmet.2011.06.003","article-title":"Hormonal regulation of hepatic glucose production in health and disease","volume":"14","author":"Lin","year":"2011","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejphar.2019.172657_bib159","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/hep.25772","article-title":"Nonalcoholic Steatohepatitis Clinical Research Network. Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis","volume":"56","author":"Loomba","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2019.172657_bib160","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nm.2686","article-title":"Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1","volume":"18","author":"Lu","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2019.172657_bib161","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1172\/JCI25604","article-title":"Farnesoid X receptor is essential for normal glucose homeostasis","volume":"116","author":"Ma","year":"2006","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2019.172657_bib162","doi-asserted-by":"crossref","first-page":"9871","DOI":"10.1074\/jbc.271.17.9871","article-title":"Glucose regulates in vivo glucose-6-phosphatase gene expression in the liver of diabetic rats","volume":"271","author":"Massillon","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172657_bib163","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1172\/JCI200318816","article-title":"PKCl in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity","volume":"112","author":"Matsumoto","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2019.172657_bib164","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4161\/isl.1.3.9608","article-title":"Control of insulin granule dynamics by AMPK dependent KLC1 phosphorylation","volume":"1","author":"McDonald","year":"2009","journal-title":"Islets"},{"key":"10.1016\/j.ejphar.2019.172657_bib165","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2337\/diabetes.54.6.1649","article-title":"Pulsatile insulin secretion dictates systemic insulin delivery by regulating hepatic insulin extraction in humans","volume":"54","author":"Meier","year":"2005","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.ejphar.2019.172657_bib166","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1097-2765(05)00015-8","article-title":"Loss of insulin signalling in hepatocyes leads tosevere insulin resistance and progressive hepatic dysfunction","volume":"6","author":"Michael","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2019.172657_bib167","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0968-0004(99)01375-4","article-title":"Regulation of protein kinase cascades by protein phosphatase 2A","volume":"24","author":"Millward","year":"1999","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejphar.2019.172657_bib168","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1194\/jlr.M800248-JLR200","article-title":"Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice","volume":"49","author":"Minehira","year":"2008","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.ejphar.2019.172657_bib169","first-page":"389","article-title":"The role of AMP kinase in diabetes","volume":"125","author":"Misra","year":"2007","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.ejphar.2019.172657_bib170","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2337\/diab.45.7.891","article-title":"Glucose-6-phosphatase mRNA and activity are increased to the same extent in kidney and liver of diabetic rats","volume":"45","author":"Mithieux","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2019.172657_bib171","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2010.03.052","article-title":"Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice","volume":"139","author":"Miura","year":"2010","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.ejphar.2019.172657_bib172","first-page":"729","article-title":"Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism","volume":"5","author":"Miyazaki","year":"2012","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2019.172657_bib173","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cmet.2007.05.005","article-title":"Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver","volume":"6","author":"Monetti","year":"2007","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejphar.2019.172657_bib174","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3389\/fphar.2018.01566","article-title":"Potential nexus of non-alcoholic fatty liver disease and type 2 diabetes mellitus: insulin resistance between hepatic and peripheral tissues","volume":"9","author":"Mu","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172657_bib175","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev.med.52.1.239","article-title":"New oral therapies for type 2 diabetes mellitus: the glitazones or insulin sensitizers","volume":"52","author":"Mudaliar","year":"2001","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ejphar.2019.172657_bib176","doi-asserted-by":"crossref","first-page":"10350","DOI":"10.1073\/pnas.89.21.10350","article-title":"IRS-1 activates phosphatidylinositol 30-kinase by associating with src homology 2 domains of p85","volume":"89","author":"Myers","year":"1992","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejphar.2019.172657_bib177","doi-asserted-by":"crossref","first-page":"12639","DOI":"10.1038\/ncomms12639","article-title":"MARCH1 regulates insulin sensitivity by controlling cell surface insulin receptor levels","volume":"7","author":"Nagarajan","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2019.172657_bib178","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1043-2760(02)00608-2","article-title":"Regulation of insulin action by CEA CAM1","volume":"13","author":"Najjar","year":"2002","journal-title":"Trends Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ejphar.2019.172657_bib179","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3892\/ijmm.2017.2899","article-title":"A long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, as a preventive drug for the development of hepatic steatosis in high-fructose diet-fed ob\/ob mice","volume":"39","author":"Nakamura","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejphar.2019.172657_bib180","doi-asserted-by":"crossref","first-page":"20517","DOI":"10.1073\/pnas.0610290104","article-title":"FoxO cription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases","volume":"104","author":"Ni","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejphar.2019.172657_bib181","first-page":"F857","article-title":"Luminal and basolateral uptake of insulin in isolated, perfused, proximal tubules","volume":"253","author":"Nielsen","year":"1987","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2019.172657_bib182","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.4161\/cc.10.14.16586","article-title":"mTOR complex 2 signaling and functions","volume":"10","author":"Oh","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejphar.2019.172657_bib183","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.1152\/ajpendo.1982.243.1.E15","article-title":"Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus","volume":"243","author":"Olefsky","year":"1982","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.ejphar.2019.172657_bib184","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2337\/diab.39.9.1009","article-title":"The insulin receptor. A multifunctional protein","volume":"39","author":"Olefsky","year":"1990","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2019.172657_bib185","doi-asserted-by":"crossref","first-page":"20462","DOI":"10.1074\/jbc.R114.576355","article-title":"Pathway-selective insulin resistance and metabolic disease: the importance of nutrient flux","volume":"289","author":"Otero","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172657_bib186","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/333664a0","article-title":"Vascular endothelial cells synthesize nitric oxide from L-arginine","volume":"333","author":"Palmer","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2019.172657_bib187","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm.2099","article-title":"The regulatory subunits of PI3K, p85a and p85b, interact with XBP-1 and increase its nuclear translocation","volume":"16","author":"Park","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2019.172657_bib188","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrm2822","article-title":"The nuts and bolts of AGC protein kinases","volume":"11","author":"Pearce","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2019.172657_bib189","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.cell.2015.01.012","article-title":"Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes","volume":"160","author":"Perry","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2019.172657_bib190","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nature13478","article-title":"The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes","volume":"510","author":"Perry","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2019.172657_bib191","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1172\/JCI86013","article-title":"Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance","volume":"126","author":"Petersen","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2019.172657_bib192","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/ng840","article-title":"CEA CAM1 regulates insulin clearance in liver","volume":"30","author":"Poy","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejphar.2019.172657_bib193","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.2337\/diab.42.12.1694","article-title":"Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate but not fasting hyperglycemia or total hepatic glucose production in NIDDM","volume":"42","author":"Puhakainen","year":"1993","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2019.172657_bib194","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13098-015-0102-8","article-title":"Treatment with the SGLT2 inhibitor luseogliflozin improves nonalcoholic steatohepatitis in a rodent model with diabetes mellitus","volume":"7","author":"Qiang","year":"2015","journal-title":"Diabetol. Metab. Syndrome"},{"key":"10.1016\/j.ejphar.2019.172657_bib195","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1172\/JCI104678","article-title":"Role of free fatty acids in forearm metabolism in man, quantitated by use of insulin","volume":"41","author":"Rabinowitz","year":"1962","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2019.172657_bib196","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF00304849","article-title":"The renal metabolism of insulin","volume":"27","author":"Rabkin","year":"1984","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.ejphar.2019.172657_bib197","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1172\/JCI69035","article-title":"Glucagon regulates gluconeogenesis through KAT2B- and WDR5-mediated epigenetic effects","volume":"123","author":"Ravnskjaer","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2019.172657_bib198","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.2337\/diab.44.9.1038","article-title":"Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin","volume":"44","author":"Rebrin","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2019.172657_bib199","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00125-003-1153-1","article-title":"Insulin granule dynamics in pancreatic beta cells","volume":"46","author":"Rorsman","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2019.172657_bib200","doi-asserted-by":"crossref","first-page":"45777","DOI":"10.1074\/jbc.M301977200","article-title":"Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-a, overexpressed in human fat cells from insulin-resistant subjects","volume":"278","author":"Rotter","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172657_bib201","doi-asserted-by":"crossref","first-page":"42394","DOI":"10.1074\/jbc.C200444200","article-title":"SOCS-1 and SOCS-3 block insulin signaling by ubiquitin- mediated degradation of IRS1 and IRS2","volume":"277","author":"Rui","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172657_bib202","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1007\/s00125-017-4432-y","article-title":"Liver-specific reconstitution of CEA CAM1 reverses the metabolic abnormalities caused by its global deletion in male mice","volume":"60","author":"Russo","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2019.172657_bib203","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hep.23861","article-title":"Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity","volume":"52","author":"Sachithanandan","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2019.172657_bib204","doi-asserted-by":"crossref","first-page":"E29","DOI":"10.1152\/ajpendo.90331.2008","article-title":"Emerging role for AS160\/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic","volume":"295","author":"Sakamoto","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2019.172657_bib205","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1172\/JCI30400","article-title":"Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease","volume":"117","author":"Samuel","year":"2007","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2019.172657_bib206","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1172\/JCI77812","article-title":"The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux","volume":"126","author":"Samuel","year":"2016","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.ejphar.2019.172657_bib207","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2019.172657_bib208","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ejphar.2019.172657_bib209","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.diabet.2019.01.008","article-title":"Beneficial effects of SGLT2 inhibitors on fatty liver in type 2 diabetes: a common comorbidity associated with severe complications","volume":"45","author":"Scheen","year":"2019","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.ejphar.2019.172657_bib210","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1172\/JCI34260","article-title":"Insulin sensitivity: modulation by nutrients and inflammation","volume":"118","author":"Schenk","year":"2008","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2019.172657_bib211","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3109\/13813455.2010.539236","article-title":"Promiscuous affairs of PKB\/AKT isoforms in metabolism","volume":"117","author":"Schultze","year":"2011","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.ejphar.2019.172657_bib212","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/35007534","article-title":"Central nervous system control of food intake","volume":"404","author":"Schwartz","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2019.172657_bib213","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12944-015-0123-1","article-title":"The role of fatty acids in insulin resistance","volume":"14","author":"Sears","year":"2015","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.ejphar.2019.172657_bib214","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.4161\/cc.10.11.15824","article-title":"The insulin receptor substrate (IRS) proteins: at the intersection of metabolism and cancer","volume":"10","author":"Shaw","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejphar.2019.172657_bib215","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/dom.13520","article-title":"Evaluation of the effects of dapagliflozin, an SGLT2 inhibitor, on hepatic steatosis and fibrosis by transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease","volume":"21","author":"Shimizu","year":"2019","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ejphar.2019.172657_bib216","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1097-2765(05)00010-9","article-title":"Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob\/ob mice","volume":"6","author":"Shimomura","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2019.172657_bib217","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.bbrc.2005.02.047","article-title":"Meg 1\/Grb10 overexpression causes postnatal growth retardation and insulin resistance via negative modulation of the IGF1R and IR cascades","volume":"329","author":"Shiura","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"Suppl. 3","key":"10.1016\/j.ejphar.2019.172657_bib218","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1038\/sj.ijo.0802501","article-title":"Inflammation and the IKK beta\/I kappa B\/NF-kappa B axis in obesity- and diet-induced insulin resistance","volume":"27","author":"Shoelson","year":"2003","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.ejphar.2019.172657_bib219","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/diab.46.2.187","article-title":"The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog","volume":"46","author":"Sindelar","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2019.172657_bib220","doi-asserted-by":"crossref","first-page":"41294","DOI":"10.1074\/jbc.M406514200","article-title":"Fatty acid-induced insulin resistance in L6 myotubes is prevented by inhibition of activation and nuclear localization of nuclear factor k B","volume":"279","author":"Sinha","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172657_bib221","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nm1178","article-title":"Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity","volume":"11","author":"Sleeman","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2019.172657_bib222","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1128\/MCB.02087-06","article-title":"Mice with a disruption of the imprinted Grb10 gene exhibit altered body composition, glucose homeostasis, and insulin signaling during postnatal life","volume":"27","author":"Smith","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejphar.2019.172657_bib223","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1172\/JCI108155","article-title":"Insulin receptor deficiency in genetic and acquired obesity","volume":"56","author":"Soli","year":"1975","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2019.172657_bib224","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1016\/S0021-9258(19)41358-6","article-title":"Insulin binding to liver plasm membranes in the obese hyperglycemic (ob\/ob) mouse. Demonstration of a decreased number of functionally normal receptors","volume":"250","author":"Soll","year":"1975","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172657_bib225","first-page":"4491","article-title":"Direct measurement of pulsatile insulin secretion from the portal vein in human subjects","volume":"85","author":"Song","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2019.172657_bib226","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1172\/JCI117433","article-title":"Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release","volume":"94","author":"Steinberg","year":"1994","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2019.172657_bib227","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1055\/s-2007-1013604","article-title":"The relationship between plasma concentration and disappearance rate of immunoreactive insulin in the conscious dog","volume":"17","author":"Stevenson","year":"1985","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ejphar.2019.172657_bib228","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/hepr.13236","article-title":"Effect of luseogliflozin on hepatic fat content in type 2 diabetes patients with non-alcoholic fatty liver disease: a prospective, single-arm trial (LEAD trial)","volume":"49","author":"Sumida","year":"2019","journal-title":"714 Hepatol. Res."},{"key":"10.1016\/j.ejphar.2019.172657_bib229","doi-asserted-by":"crossref","first-page":"23301","DOI":"10.1074\/jbc.M200964200","article-title":"Phosphoenol pyruvate carboxykinase overexpression selectively attenuates insulin signalling and hepatic insulin sensitivity in transgenic mice","volume":"277","author":"Sun","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172657_bib230","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1517\/14728222.2010.492780","article-title":"SHIP2 and its involvement in various diseases","volume":"14","author":"Suwa","year":"2010","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejphar.2019.172657_bib231","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ejphar.2013.05.014","article-title":"Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice","volume":"715","author":"Tahara","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172657_bib232","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI11830","article-title":"NF-kappaB: a key role in inflammatory diseases","volume":"107","author":"Tak","year":"2001","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2019.172657_bib233","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1158\/0008-5472.CAN-09-3399","article-title":"The phosphoinositide 3-kinase regulatory subunit p85a can exert tumor suppressor properties through negative regulation of growth factor signaling","volume":"70","author":"Taniguchi","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2019.172657_bib234","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-1-4684-5949-4_19","article-title":"Mutations in the insulin receptor gene in patients with genetic syndromes of insulin resistance","volume":"293","author":"Taylor","year":"1991","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejphar.2019.172657_bib235","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/6023","article-title":"Increased insulin sensitivity and hypoglycaemia in mice lacking the p85 a subunit of phosphoinositide 3-kinase","volume":"21","author":"Terauchi","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejphar.2019.172657_bib236","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.2337\/diabetes.50.11.2563","article-title":"Ceramide mediates insulin resistance by tumor necrosis factor-a in brown adipocytes by maintaining Akt in an inactive dephosphorylated state","volume":"50","author":"Teruel","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2019.172657_bib237","doi-asserted-by":"crossref","first-page":"7078","DOI":"10.1038\/ncomms8078","article-title":"Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo","volume":"6","author":"Titchenell","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2019.172657_bib238","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.cmet.2016.04.022","article-title":"Direct hepatocyte insulin signaling is required for lipogenesis but is dispensable for the suppression of glucose production","volume":"23","author":"Titchenell","year":"2016","journal-title":"Cell Metabol."},{"issue":"7","key":"10.1016\/j.ejphar.2019.172657_bib239","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1083\/jcb.201802095","article-title":"The cell biology of systemic insulin function","volume":"217","author":"Tokarz","year":"2018","journal-title":"J. Cell Biol."},{"issue":"48","key":"10.1016\/j.ejphar.2019.172657_bib240","doi-asserted-by":"crossref","first-page":"31615","DOI":"10.1074\/jbc.273.47.31615","article-title":"Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats","volume":"273","author":"Trinh","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172657_bib241","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.bbamcr.2011.06.002","article-title":"FoxO cription factors; Regulation by AKT and 14\u20133-3 proteins","volume":"1813","author":"Tzivion","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2019.172657_bib242","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1128\/MCB.24.12.5434-5446.2004","article-title":"Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms","volume":"24","author":"Ueki","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejphar.2019.172657_bib243","doi-asserted-by":"crossref","first-page":"10422","DOI":"10.1073\/pnas.0402511101","article-title":"Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse","volume":"101","author":"Ueki","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejphar.2019.172657_bib244","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1073\/pnas.012581799","article-title":"Increased insulin sensitivity in mice lacking p85b subunit of phosphoinositide 3-kinase","volume":"99","author":"Ueki","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejphar.2019.172657_bib245","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/39335","article-title":"Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function","volume":"389","author":"Uysal","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2019.172657_bib246","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1172\/JCI115432","article-title":"Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus","volume":"88","author":"Vaag","year":"1991","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.ejphar.2019.172657_bib247","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/ptr.4763","article-title":"Anti-diabetic activity of swertiamarin is due to an active metabolite, gentianine, that upregulates PPAR-\u0393 gene expression in 3t3-L1 cells","volume":"27","author":"Vaidya","year":"2012","journal-title":"Phyother. Res."},{"issue":"8","key":"10.1016\/j.ejphar.2019.172657_bib248","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/ptr.3708","article-title":"Beneficial effects of swertiamarin on dyslipidaemia in streptozotocin-induced type 2 diabetic rats","volume":"26","author":"Vaidya","year":"2012","journal-title":"Phytother Res."},{"issue":"4","key":"10.1016\/j.ejphar.2019.172657_bib249","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4103\/0976-500X.142429","article-title":"Acetylated and propionated derivatives of swertiamarin have anti-adipogenic effects","volume":"5","author":"Vaidya","year":"2014","journal-title":"J. Pharmacol. Pharmacother."},{"key":"10.1016\/j.ejphar.2019.172657_bib250","doi-asserted-by":"crossref","first-page":"9151","DOI":"10.1073\/pnas.91.19.9151","article-title":"Transgenic mice overexpressing phosphoenolpyruvatecarboxykinase develop non-insulin-dependent diabetes mellitus","volume":"91","author":"Valera","year":"1994","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2019.172657_bib251","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ncb1547","article-title":"Insulin signalling to mTOR mediated by the Akt\/PKB substrate PRAS40","volume":"9","author":"Vander Haar","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejphar.2019.172657_bib252","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1126\/science.1171529","article-title":"A role for the CHC22 clathrin heavy-chain isoform in human glucose metabolism","volume":"324","author":"Vassilopoulos","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2019.172657_bib253","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2337\/diabetes.51.1.42","article-title":"Skeletal muscle microvascular recruitment by physiological hyperinsulinemia precedes increases in total blood flow","volume":"51","author":"Vincent","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2019.172657_bib254","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1096\/fj.10-167361","article-title":"Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-\u03b2 peptide degradation","volume":"25","author":"Vingtdeux","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2019.172657_bib255","article-title":"Fatty acid metabolism: target for metabolic syndrome","volume":"S138\u2013 S143","author":"Wakil","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2019.172657_bib256","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.1128\/MCB.00679-07","article-title":"Peripheral disruption of the Grb10 gene enhances insulin signaling and sensitivity in vivo","volume":"27","author":"Wang","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejphar.2019.172657_bib257","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejphar.2016.08.038","article-title":"HNF-4\u03b1 regulated miR-122 contributes to development of gluconeogenesis and lipid metabolism disorders in Type 2 diabetic mice and in palmitate-treated HepG2 cells","volume":"791","author":"Wei","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172657_bib258","doi-asserted-by":"crossref","first-page":"22689","DOI":"10.1074\/jbc.270.39.22689","article-title":"Ceramide activates the stress-activated protein kinases","volume":"270","author":"Westwick","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172657_bib259","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1128\/MCB.25.3.1135-1145.2005","article-title":"Muscle-specific Pten deletion protects against insulin resistance and diabetes","volume":"25","author":"Wijesekara","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejphar.2019.172657_bib260","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.1999.277.1.E1","article-title":"AMP-activated protein kinase, a metabolic master switch: possible roles in Type 2 diabetes","volume":"277","author":"Winder","year":"1999","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2019.172657_bib261","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nm.2121","article-title":"A regulatory subunit of phosphoinositide 3-kinase increases the nuclear accumulation of X-box-binding protein-1 to modulate the unfolded protein response","volume":"16","author":"Winnay","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2019.172657_bib262","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.cell.2008.12.040","article-title":"A role of DNA-PK for the metabolic gene regulation in response to insulin","volume":"136","author":"Wong","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2019.172657_bib263","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2174\/1381612033455323","article-title":"Insulin and the blood-brain barrier","volume":"9","author":"Woods","year":"2003","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejphar.2019.172657_bib264","first-page":"717","article-title":"Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in noninsulin-dependent diabetes mellitus patients during a 3-day intensified treatment period","volume":"78","author":"Worm","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2019.172657_bib265","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/ATVBAHA.111.244525","article-title":"NOX4 pathway as a source of selective insulin resistance and responsiveness","volume":"32","author":"Wu","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.ejphar.2019.172657_bib266","doi-asserted-by":"crossref","DOI":"10.1172\/JCI104130","article-title":"Immunoassay of endogenous plasma insulin in man","volume":"39","author":"Yalow","year":"1960","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2019.172657_bib267","doi-asserted-by":"crossref","first-page":"41245","DOI":"10.1074\/jbc.M103241200","article-title":"The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPAR\u03b3 agonist improve insulin resistance","volume":"276","author":"Yamauchi","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.ejphar.2019.172657_bib268","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41580-018-0044-8","article-title":"Metabolites as regulators of insulin sensitivity and metabolism","volume":"19","author":"Yang","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2019.172657_bib269","doi-asserted-by":"crossref","first-page":"50230","DOI":"10.1074\/jbc.M200958200","article-title":"Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)- associated phosphatidylinositol 3-kinase activity in muscle","volume":"277","author":"Yu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172657_bib270","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1161\/01.CIR.101.13.1539","article-title":"Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells","volume":"101","author":"Zeng","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2019.172657_bib271","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1073\/pnas.1110730109","article-title":"Glycerolipid signals alter mTOR complex 2 (mTORC2) to diminish insulin signalling","volume":"109","author":"Zhang","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejphar.2019.172657_bib272","doi-asserted-by":"crossref","first-page":"35375","DOI":"10.1074\/jbc.M806480200","article-title":"S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-a signaling through IKK2","volume":"283","author":"Zhang","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172657_bib273","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1073\/pnas.0506982103","article-title":"Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2019.172657_bib274","first-page":"8309723","article-title":"Dipeptidyl-peptidase 4 inhibitor sitagliptin ameliorates hepatic insulin resistance by modulating inflammation and autophagy in ob\/ob mice","volume":"2018","author":"Zheng","year":"2018","journal-title":"Internet J. Endocrinol."},{"issue":"8","key":"10.1016\/j.ejphar.2019.172657_bib275","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J. Clin. Investig."},{"issue":"10","key":"10.1016\/j.ejphar.2019.172657_bib276","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.2337\/db16-0317","article-title":"DPP-4 inhibition by linagliptin attenuates obesity-related inflammation and insulin resistance by regulating M1\/M2 macrophage polarization","volume":"65","author":"Zhuge","year":"2016","journal-title":"Diabetes"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919306090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919306090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:31:52Z","timestamp":1757975512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299919306090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":276,"alternative-id":["S0014299919306090"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172657","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver and insulin resistance: New wine in old bottle!!!","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172657","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"172657"}}